S&P 500   4,552.14 (-0.33%)
DOW   36,067.39 (-0.16%)
QQQ   385.69 (-0.41%)
AAPL   192.59 (-0.43%)
MSFT   369.26 (-0.88%)
META   317.52 (-0.24%)
GOOGL   130.11 (-0.67%)
AMZN   144.98 (-1.29%)
TSLA   241.49 (+1.16%)
NVDA   456.85 (-1.89%)
NIO   7.84 (+5.52%)
BABA   71.85 (-0.73%)
AMD   116.80 (-1.33%)
T   17.00 (-1.28%)
F   10.74 (+1.32%)
MU   73.05 (-0.87%)
CGC   0.71 (+6.57%)
GE   120.22 (+-0.01%)
DIS   91.65 (+0.95%)
AMC   6.85 (-2.42%)
PFE   28.84 (-0.86%)
PYPL   59.86 (+3.35%)
XOM   98.99 (-1.44%)
S&P 500   4,552.14 (-0.33%)
DOW   36,067.39 (-0.16%)
QQQ   385.69 (-0.41%)
AAPL   192.59 (-0.43%)
MSFT   369.26 (-0.88%)
META   317.52 (-0.24%)
GOOGL   130.11 (-0.67%)
AMZN   144.98 (-1.29%)
TSLA   241.49 (+1.16%)
NVDA   456.85 (-1.89%)
NIO   7.84 (+5.52%)
BABA   71.85 (-0.73%)
AMD   116.80 (-1.33%)
T   17.00 (-1.28%)
F   10.74 (+1.32%)
MU   73.05 (-0.87%)
CGC   0.71 (+6.57%)
GE   120.22 (+-0.01%)
DIS   91.65 (+0.95%)
AMC   6.85 (-2.42%)
PFE   28.84 (-0.86%)
PYPL   59.86 (+3.35%)
XOM   98.99 (-1.44%)
S&P 500   4,552.14 (-0.33%)
DOW   36,067.39 (-0.16%)
QQQ   385.69 (-0.41%)
AAPL   192.59 (-0.43%)
MSFT   369.26 (-0.88%)
META   317.52 (-0.24%)
GOOGL   130.11 (-0.67%)
AMZN   144.98 (-1.29%)
TSLA   241.49 (+1.16%)
NVDA   456.85 (-1.89%)
NIO   7.84 (+5.52%)
BABA   71.85 (-0.73%)
AMD   116.80 (-1.33%)
T   17.00 (-1.28%)
F   10.74 (+1.32%)
MU   73.05 (-0.87%)
CGC   0.71 (+6.57%)
GE   120.22 (+-0.01%)
DIS   91.65 (+0.95%)
AMC   6.85 (-2.42%)
PFE   28.84 (-0.86%)
PYPL   59.86 (+3.35%)
XOM   98.99 (-1.44%)
S&P 500   4,552.14 (-0.33%)
DOW   36,067.39 (-0.16%)
QQQ   385.69 (-0.41%)
AAPL   192.59 (-0.43%)
MSFT   369.26 (-0.88%)
META   317.52 (-0.24%)
GOOGL   130.11 (-0.67%)
AMZN   144.98 (-1.29%)
TSLA   241.49 (+1.16%)
NVDA   456.85 (-1.89%)
NIO   7.84 (+5.52%)
BABA   71.85 (-0.73%)
AMD   116.80 (-1.33%)
T   17.00 (-1.28%)
F   10.74 (+1.32%)
MU   73.05 (-0.87%)
CGC   0.71 (+6.57%)
GE   120.22 (+-0.01%)
DIS   91.65 (+0.95%)
AMC   6.85 (-2.42%)
PFE   28.84 (-0.86%)
PYPL   59.86 (+3.35%)
XOM   98.99 (-1.44%)

Curaleaf Stock Price, News & Analysis (OTCMKTS:CURLF)

$3.95
+0.09 (+2.33%)
(As of 12/5/2023 ET)
Compare
Today's Range
$3.74
$3.96
50-Day Range
$2.61
$4.57
52-Week Range
$2.19
$7.88
Volume
524,388 shs
Average Volume
589,647 shs
Market Capitalization
$2.50 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.00

Curaleaf MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.63 Rating Score
Upside/​Downside
229.1% Upside
$13.00 Price Target
Short Interest
Healthy
0.80% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.30) to ($0.14) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.77 out of 5 stars


CURLF stock logo

About Curaleaf Stock (OTCMKTS:CURLF)

Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates through Domestic Operations and International Operations segments. The company engages in the cultivation, production, and sale of cannabis products through retail and wholesale channels. In addition, it offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. Further, the company provides hemp-based CBD and cannabigerol products. The company was founded in 2010 and is headquartered in New York, New York.

CURLF Stock Price History

CURLF Stock News Headlines

Curaleaf Opens Second Dispensary in Sarasota, FL
Critical Contrast: biote (NASDAQ:BTMD) vs. Curaleaf (OTCMKTS:CURLF)
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity
Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Curaleaf Reports Third Quarter 2023 Results
Curaleaf analysts eye gross margin, free cash flow in 3Q results
Curaleaf confirms layoffs ahead of potential TSX uplisting
Curaleaf Applies to List Shares in Canada
See More Headlines
Receive CURLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Curaleaf and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/09/2023
Today
12/06/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
OTCMKTS:CURLF
Fax
N/A
Employees
5,931
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.00
High Stock Price Target
$32.25
Low Stock Price Target
$4.25
Potential Upside/Downside
+229.1%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.63
Research Coverage
8 Analysts

Profitability

Net Income
$-370,100,000.00
Pretax Margin
-25.24%

Debt

Sales & Book Value

Annual Sales
$1.34 billion
Book Value
$2.07 per share

Miscellaneous

Free Float
N/A
Market Cap
$2.50 billion
Optionable
Not Optionable
Beta
1.83
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Boris Alexis Jordan (Age 57)
    Executive Chairman
    Comp: $1.75M
  • Mr. Matthew S. Darin
    Chief Executive Officer
  • Mr. Joseph F. Lusardi (Age 49)
    Executive Vice-Chairman
    Comp: $657.7k
  • Mr. Edward Kremer (Age 51)
    Chief Financial Officer
    Comp: $461.74k
  • Mr. Joe Holland
    Executive Vice President of Operations
  • Mr. Camilo Russi Lyon
    Chief Investment Officer
  • Mr. Jakob Feinstein
    Manager of Investor Relations
  • Mr. Peter Laurence Clateman J.D. (Age 55)
    Chief Legal Officer
  • Mr. James S. Shorris (Age 61)
    Chief Compliance Officer
  • Ms. Tracy Brady
    Senior Vice President of Corporate Communications














CURLF Stock Analysis - Frequently Asked Questions

Should I buy or sell Curaleaf stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Curaleaf in the last year. There are currently 1 sell rating, 1 hold rating and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CURLF shares.
View CURLF analyst ratings
or view top-rated stocks.

What is Curaleaf's stock price target for 2024?

8 Wall Street analysts have issued 12 month price targets for Curaleaf's stock. Their CURLF share price targets range from $4.25 to $32.25. On average, they predict the company's share price to reach $13.00 in the next year. This suggests a possible upside of 229.1% from the stock's current price.
View analysts price targets for CURLF
or view top-rated stocks among Wall Street analysts.

How have CURLF shares performed in 2023?

Curaleaf's stock was trading at $4.2973 at the beginning of the year. Since then, CURLF stock has decreased by 8.1% and is now trading at $3.95.
View the best growth stocks for 2023 here
.

Are investors shorting Curaleaf?

Curaleaf saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 5,209,000 shares, an increase of 19.3% from the October 15th total of 4,367,200 shares. Based on an average trading volume of 1,434,900 shares, the days-to-cover ratio is presently 3.6 days.
View Curaleaf's Short Interest
.

How were Curaleaf's earnings last quarter?

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) released its quarterly earnings results on Thursday, November, 9th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.06) by $0.03. The company earned $333.17 million during the quarter, compared to analysts' expectations of $341.07 million. Curaleaf had a negative net margin of 35.15% and a negative trailing twelve-month return on equity of 25.33%.

How do I buy shares of Curaleaf?

Shares of CURLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (OTCMKTS:CURLF) was last updated on 12/6/2023 by MarketBeat.com Staff

My Account -